vs
GE医疗（CCRN）与Rapid7, Inc.（RPD）财务数据对比。点击上方公司名可切换其他公司
GE医疗的季度营收约是Rapid7, Inc.的1.1倍（$236.8M vs $217.4M），Rapid7, Inc.净利率更高（1.4% vs -35.0%，领先36.5%），Rapid7, Inc.同比增速更快（0.5% vs -23.6%），Rapid7, Inc.自由现金流更多（$36.4M vs $16.1M），过去两年Rapid7, Inc.的营收复合增速更高（3.0% vs -21.0%）
GE医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，品牌标识为GE HealthCare。公司主要业务分为四大板块：包含分子影像、CT、磁共振、妇科筛查及X光设备的医学影像业务、超声业务，以及聚焦远程患者监测、麻醉呼吸护理、心脏诊断、婴幼儿护理的患者护理解决方案业务，此外还开展医药相关业务。
Rapid7是全球领先的网络安全企业，提供漏洞管理、威胁检测与响应、云安全、安全分析等全系列安全解决方案，服务全球科技、医疗、金融、制造等行业的各类规模企业及公共部门客户，助力客户高效识别、应对和缓解网络安全风险。
CCRN vs RPD — 直观对比
营收规模更大
CCRN
是对方的1.1倍
$217.4M
营收增速更快
RPD
高出24.1%
-23.6%
净利率更高
RPD
高出36.5%
-35.0%
自由现金流更多
RPD
多$20.3M
$16.1M
两年增速更快
RPD
近两年复合增速
-21.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $236.8M | $217.4M |
| 净利润 | $-82.9M | $3.1M |
| 毛利率 | — | 68.9% |
| 营业利润率 | -30.2% | 1.0% |
| 净利率 | -35.0% | 1.4% |
| 营收同比 | -23.6% | 0.5% |
| 净利润同比 | -2109.7% | 44.1% |
| 每股收益（稀释后） | $-2.56 | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCRNRPD
| Q4 25 | $236.8M | $217.4M | ||
| Q3 25 | $250.1M | $218.0M | ||
| Q2 25 | $274.1M | $214.2M | ||
| Q1 25 | $293.4M | $210.3M | ||
| Q4 24 | $309.9M | $216.3M | ||
| Q3 24 | $315.1M | $214.7M | ||
| Q2 24 | $339.8M | $208.0M | ||
| Q1 24 | $379.2M | $205.1M |
净利润CCRNRPD
| Q4 25 | $-82.9M | $3.1M | ||
| Q3 25 | $-4.8M | $9.8M | ||
| Q2 25 | $-6.7M | $8.3M | ||
| Q1 25 | $-490.0K | $2.1M | ||
| Q4 24 | $-3.8M | $2.2M | ||
| Q3 24 | $2.6M | $15.4M | ||
| Q2 24 | $-16.1M | $6.5M | ||
| Q1 24 | $2.7M | $1.4M |
毛利率CCRNRPD
| Q4 25 | — | 68.9% | ||
| Q3 25 | 20.4% | 70.2% | ||
| Q2 25 | 20.4% | 70.6% | ||
| Q1 25 | 20.0% | 71.7% | ||
| Q4 24 | — | 69.5% | ||
| Q3 24 | 20.4% | 70.6% | ||
| Q2 24 | 20.8% | 70.7% | ||
| Q1 24 | 20.4% | 70.3% |
营业利润率CCRNRPD
| Q4 25 | -30.2% | 1.0% | ||
| Q3 25 | -2.4% | 2.7% | ||
| Q2 25 | -2.1% | 1.6% | ||
| Q1 25 | -0.3% | -0.0% | ||
| Q4 24 | -1.1% | 3.4% | ||
| Q3 24 | 0.9% | 6.0% | ||
| Q2 24 | -5.7% | 2.5% | ||
| Q1 24 | 0.8% | 4.7% |
净利率CCRNRPD
| Q4 25 | -35.0% | 1.4% | ||
| Q3 25 | -1.9% | 4.5% | ||
| Q2 25 | -2.4% | 3.9% | ||
| Q1 25 | -0.2% | 1.0% | ||
| Q4 24 | -1.2% | 1.0% | ||
| Q3 24 | 0.8% | 7.2% | ||
| Q2 24 | -4.7% | 3.1% | ||
| Q1 24 | 0.7% | 0.7% |
每股收益（稀释后）CCRNRPD
| Q4 25 | $-2.56 | $0.05 | ||
| Q3 25 | $-0.15 | $0.15 | ||
| Q2 25 | $-0.20 | $0.13 | ||
| Q1 25 | $-0.02 | $0.03 | ||
| Q4 24 | $-0.13 | $0.08 | ||
| Q3 24 | $0.08 | $0.21 | ||
| Q2 24 | $-0.47 | $0.09 | ||
| Q1 24 | $0.08 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $108.7M | $474.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $322.8M | $154.7M |
| 总资产 | $449.0M | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CCRNRPD
| Q4 25 | $108.7M | $474.7M | ||
| Q3 25 | $99.1M | $407.1M | ||
| Q2 25 | $81.2M | $511.7M | ||
| Q1 25 | $80.7M | $493.5M | ||
| Q4 24 | $81.6M | $521.7M | ||
| Q3 24 | $64.0M | $443.7M | ||
| Q2 24 | $69.6M | $442.6M | ||
| Q1 24 | $5.2M | $411.7M |
股东权益CCRNRPD
| Q4 25 | $322.8M | $154.7M | ||
| Q3 25 | $408.1M | $127.2M | ||
| Q2 25 | $412.2M | $90.4M | ||
| Q1 25 | $418.2M | $52.7M | ||
| Q4 24 | $419.0M | $17.7M | ||
| Q3 24 | $424.7M | $-5.1M | ||
| Q2 24 | $433.3M | $-52.6M | ||
| Q1 24 | $462.4M | $-86.4M |
总资产CCRNRPD
| Q4 25 | $449.0M | $1.7B | ||
| Q3 25 | $538.2M | $1.7B | ||
| Q2 25 | $553.8M | $1.6B | ||
| Q1 25 | $576.2M | $1.6B | ||
| Q4 24 | $589.3M | $1.7B | ||
| Q3 24 | $597.4M | $1.6B | ||
| Q2 24 | $602.9M | $1.5B | ||
| Q1 24 | $648.4M | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $18.2M | $37.6M |
| 自由现金流经营现金流 - 资本支出 | $16.1M | $36.4M |
| 自由现金流率自由现金流/营收 | 6.8% | 16.8% |
| 资本支出强度资本支出/营收 | 0.9% | 0.5% |
| 现金转化率经营现金流/净利润 | — | 12.01× |
| 过去12个月自由现金流最近4个季度 | $40.1M | $146.2M |
8季度趋势，按日历期对齐
经营现金流CCRNRPD
| Q4 25 | $18.2M | $37.6M | ||
| Q3 25 | $20.1M | $39.0M | ||
| Q2 25 | $4.2M | $47.5M | ||
| Q1 25 | $5.7M | $29.8M | ||
| Q4 24 | $24.2M | $63.8M | ||
| Q3 24 | $7.5M | $44.0M | ||
| Q2 24 | $82.4M | $32.9M | ||
| Q1 24 | $6.0M | $31.1M |
自由现金流CCRNRPD
| Q4 25 | $16.1M | $36.4M | ||
| Q3 25 | $17.9M | $34.8M | ||
| Q2 25 | $2.3M | $46.6M | ||
| Q1 25 | $3.8M | $28.4M | ||
| Q4 24 | $21.7M | $62.6M | ||
| Q3 24 | $6.3M | $42.6M | ||
| Q2 24 | $79.6M | $32.6M | ||
| Q1 24 | $3.8M | $30.4M |
自由现金流率CCRNRPD
| Q4 25 | 6.8% | 16.8% | ||
| Q3 25 | 7.2% | 16.0% | ||
| Q2 25 | 0.8% | 21.8% | ||
| Q1 25 | 1.3% | 13.5% | ||
| Q4 24 | 7.0% | 28.9% | ||
| Q3 24 | 2.0% | 19.9% | ||
| Q2 24 | 23.4% | 15.7% | ||
| Q1 24 | 1.0% | 14.8% |
资本支出强度CCRNRPD
| Q4 25 | 0.9% | 0.5% | ||
| Q3 25 | 0.9% | 1.9% | ||
| Q2 25 | 0.7% | 0.4% | ||
| Q1 25 | 0.6% | 0.6% | ||
| Q4 24 | 0.8% | 0.5% | ||
| Q3 24 | 0.4% | 0.6% | ||
| Q2 24 | 0.8% | 0.1% | ||
| Q1 24 | 0.6% | 0.3% |
现金转化率CCRNRPD
| Q4 25 | — | 12.01× | ||
| Q3 25 | — | 3.97× | ||
| Q2 25 | — | 5.70× | ||
| Q1 25 | — | 14.14× | ||
| Q4 24 | — | 29.36× | ||
| Q3 24 | 2.92× | 2.85× | ||
| Q2 24 | — | 5.03× | ||
| Q1 24 | 2.23× | 22.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
RPD
| Products | $209.1M | 96% |
| Services | $8.2M | 4% |
